Concepedia

Publication | Open Access

Anticancer Chemosensitization and Radiosensitization by the Novel Poly(ADP-ribose) Polymerase-1 Inhibitor AG14361

DOIFull Paper Access

482

Citations

39

References

2004

Year

Christopher Calabrese, Robert J. Almassy, Stephen Barton, Michael A. Batey, A H Calvert, SS Canan-Koch, Barbara W. Durkacz, Zdeněk Hostomský, Robert A. Kumpf, Suzanne Kyle,
JNCI Journal of the National Cancer Institute

Abstract

AG14361 is, to our knowledge, the first high-potency PARP-1 inhibitor with the specificity and in vivo activity to enhance chemotherapy and radiation therapy of human cancer.

References

YearCitations

Page 1